What is the medical insurance reimbursement price of Mitotane?

Mitotane (Mitotane) is a drug used to treat adrenocortical carcinoma (ACC) and Cushing's syndrome. It is a selective poison of adrenocortical cells, reducing excess hormone production by destroying these cells. Mitotane plays an important role in treating these conditions, especially when surgery cannot completely remove the tumor or the cancer has spread.

Mitotane selectively destroys adrenocortical cells by inhibiting the synthesis of adrenocortical hormones (especially cortisol and other glucocorticoids), reducing tumor tissue and the problem of excessive hormone secretion. This mechanism makes it very effective in the treatment of adrenocortical cancer and Cushing's syndrome.

Mitotane is used to treat adrenocortical cancer (ACC), especially tumors that cannot be completely removed with surgery or that have spread. It is also used to treat Cushing's syndrome, a condition caused by too much cortisol in the body. Mitotan (Mitotan) By reducing the production of adrenocortical hormones, it helps prolong patient survival and improve symptoms.

Mitotane is currently on the market in China, but has not yet been included in medical insurance. Therefore, patients need to purchase it at their own expense. Since Mitotane has been on the market for a short time in China, it is difficult to purchase. It is recommended to consult the local hospital pharmacy for specific prices and supply conditions. Abroad, Mitotane has two options: original drug and generic drug. The original medicines are mainly European versions and are more expensive, about more than 9,000 yuan per box. In contrast, cheaper foreign generic drugs, such as Laotian generic drugs, cost about one to two thousand yuan, and the drug ingredients are basically the same as the original drugs.

Mitotane plays an important role in the treatment of adrenocortical cancer and Cushing's syndrome, but it has significant side effects and is difficult to purchase domestically. Since it is not covered by medical insurance, patients need to pay for it at their own expense, which is relatively expensive. It is recommended that patients use mitotane under the guidance of a doctor, monitor their physical condition regularly, and consult their local hospital pharmacy for the latest price and supply information. Abroad, generic drugs may be a more economical option.